Pharma Stocks Offer Defensive Shelter When Markets Turn Turbulent

Low betas, 2–4% dividends, and pipeline-driven upside make large-cap pharma a go-to refuge in downturns—but pricing risk and patent cliffs demand stock-level scrutiny.

bt-corporate · 7/15/2026, 9:19:15 AM · Ask about this →